Search Within

Catherine H Van Poznak

Formats
  1. Journal Article (25)
  2. Meeting Abstract (25)
  3. Book Section (1)
  4. Conference Paper (1)
Groups
  1. Breast Medicine Service (36)
  2. Department of Medicine (36)
  3. Solid Tumor Oncology Division (36)
  4. Survivorship Research (32)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (20)
  6. Population Sciences Research Program (18)

More Groups

People
  1. Clifford Hudis (31)
  2. Andrew Seidman (18)
  3. Larry Norton (18)
  4. Katherine Panageas (15)
  5. Monica Fornier (11)
  6. Gabriella D'Andrea-Carlino (10)

More People

Years
  1. 2009 (1)
  2. 2007 (1)
  3. 2006 (11)
  4. 2005 (9)
  5. 2004 (7)
  6. 2003 (7)

More Years

Publications
  1. Breast Cancer Research and Treatment (13)
  2. Journal of Bone and Mineral Research (5)
  3. Bone (4)
  4. Women's Oncology Review (4)
  5. Cancer Investigation (3)
  6. Journal of Clinical Oncology (3)

More Publications

Publishers
  1. Springer (14)
  2. Wiley Blackwell (11)
  3. Taylor & Francis Group (5)
  4. Elsevier Science, Inc. (4)
  5. American Society of Clinical Oncology (3)
  6. Elsevier Inc. (3)

More Publishers

Results (52)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • [Commentary on] Intravenous zoledronic acid in postmenopausal women with low bone mineral density
    Journal Article

    Van Poznak, C. H.
    Women's Oncology Review (2002)

    Fulltext@MSK | Save
  • Critical review of current treatment strategies for advanced hormone insensitive breast cancer
    Journal Article

    Van Poznak, C.; Seidman, A. D.
    Cancer Investigation (2002)

    Fulltext@MSK | Save
  • The use of bisphosphonates in patients with breast cancer
    Journal Article

    Van Poznak, C. H.
    Cancer Control (2002)

    Fulltext@MSK | Save
  • HER2 testing and correlation with efficacy of trastuzumab therapy
    Journal Article

    Fornier, M.; Risio, M.; Van Poznak, C.; Seidman, A.
    Oncology (Norwalk) (2002)

    Fulltext@MSK | Save
  • Assessment of molecular markers of clinical sensitivity to single-agent taxane therapy for metastatic breast cancer
    Journal Article

    Van Poznak, C.; Tan, L.; Panageas, K. S.; Arroyo, C. D.; Hudis, C.; Norton, L.; Seidman, A. D.
    Journal of Clinical Oncology (2002)

    Fulltext@MSK | Save
  • [Commentary on] Bone mass and breast cancer risk in older women: Differences by stage at diagnosis
    Journal Article

    Van Poznak, C. H.
    Women's Oncology Review (2001)

    Fulltext@MSK | Save
  • Commentary on "HER2/neu as a predictive factor in breast cancer"
    Journal Article

    Van Poznak, C.; Seidman, A. D.
    Clinical Breast Cancer (2001)

    Fulltext@MSK | Save
  • How are bisphosphonates used today in breast cancer clinical practice?
    Journal Article

    Van Poznak, C.
    Seminars in Oncology (2001)

    Fulltext@MSK | Save
  • Oral gossypol in the treatment of patients with refractory metastatic breast cancer: A phase I/II clinical trial
    Journal Article

    Van Poznak, C.; Seidman, A. D.; Reidenberg, M. M.; Moasser, M. M.; Sklarin, N.; Van Zee, K.; Borgen, P.; Gollub, M.; Bacotti, D.; Yao, T. J.; more...
    Breast Cancer Research and Treatment (2001)

    Fulltext@MSK | Save
  • Clinical-pathologic assessment of the clinical sensitivity to single agent taxane (T) therapy for metastatic breast cancer (MBC)
    Meeting Abstract

    Van Poznak, C.; Tan, L.; Panageas, K.; Arroyo, C.; Hudis, C.; Norton, L.; Seidman, A. D.
    Breast Cancer Research and Treatment (2000)

    Fulltext@MSK | Save